Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
Expert Review of Hematology|November 4, 2024
What are the therapeutic options for previously treated myelofibrosis?Cassandre Petit, Hugues de Lavallade, Claire Harrison
Blood Advances|April 29, 2020
Fedratinib in myelofibrosisAnn Mullally, John Hood, Claire Harrison, et al.
Public Health Nutrition|July 7, 2011
Re-imagining the 'social' in the nutrition sciencesLisa Schubert, Danielle Gallegos, Wendy Foley, et al.
Haematologica|April 4, 2020
Bone marrow niche dysregulation in myeloproliferative neoplasmsNatalia Curto-Garcia, Claire Harrison, Donal P McLornan
British Journal of Haematology|April 3, 2012
Janus kinase inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?Claire Harrison, Srdan Verstovsek, Mary F McMullin, et al.
Current Hematologic Malignancy Reports|July 3, 2023
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative DiseasesAndrea Duminuco, Elena Torre, Giuseppe A Palumbo, et al.
Applied and Environmental Microbiology|October 23, 2024
Convergent reductive evolution in bee-associated lactic acid bacteriaAna Pontes, Marie-Claire Harrison, Antonis Rokas, et al.
Thrombosis Research|May 21, 2014
Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: a physician surveyMartin H Ellis, Noa Lavi, Alessandro Vannucchi, et al.
Blood and Lymphatic Cancer : Targets and Therapy|December 26, 2023
Polycythemia Vera: Barriers to and Strategies for Optimal ManagementAndrea Duminuco, Patrick Harrington, Claire Harrison, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Convergent reductive evolution in bee-associated lactic acid bacteriaAna Pontes, Marie-Claire Harrison, Antonis Rokas, et al.
Pageof 17